September 2016 ARTICLE LIST >>
PharmaTutor (September - 2016)
Print-ISSN: 2394 - 6679
e-ISSN: 2347 - 7881
(Volume 4, Issue 9)
Received On: 17/03/2016; Accepted On: 19/04/2016; Published On: 01/09/2016
AUTHORS:
S. Ashutosh Kumar*, Manidipa Debnath, Vaddi Pavan Krishna Kumar
Department of Pharmaceutical Analysis and Quality Assurance,
A.K.R.G College of Pharmacy, West Godavari, A.P, India
*ashu.mpharm2007@gmail.com
ABSTRACT: Purpose: A simple, precise, accurate, rapid and economical reverse phase high-pressure liquid chromatographic method has been developed as per ICH norms for the estimation of Naproxen from pharmaceutical formulation.
Methods: The method was carried out on a Kromosil-C18 ODS column (150 mm X 4.6 mm; 5 μ) with a mobile phase consists of ammonium acetate buffer (adjusted to pH 4.0 with 1 % Triethyl amine): methanol (40:60 v/v) and filtered through a 0.45 μ cellulose nitrate filters. The flow rate was maintained in isocratic mode at 1.0 mL/min. The detection was carried out at 210 nm. The run time was 7.0 min.
Results: The retention time was 3.063 min for Naproxen. The developed method was validated in terms of accuracy, precision, linearity, limit of detection, limit of quantification and solution stability.
Conclusion: The proposed method was adequate sensitive, reproducible, and specific for the determination of Naproxen in bulk as well as in tablet dosage forms.
How to cite this article: Kumar SA, Debnath M, Kumar VPK; Method development and validation for estimation of Naproxen in bulk samples as well as in tablet dosage forms by using RP-HPLC; PharmaTutor; 2016; 4(9); 33-39
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. http://www.drugs.com/naproxen.html.
2. http://en.wikipedia.org/wiki/Naproxen.
3. http://www.medicinenet.com/naproxen/article.htm.
4. Sripal Reddy P, Sait S, Vasudevmurthy G, Vishwanath B, Prasad V, and Jayapal Reddy S; Stability indicating simultaneous estimation of assay method for naproxen and Esomeprazole in pharmaceutical formulations by RP-HPLC; Der Pharma Chemical; 2011; 3(6); 553–564.
5. Ekpe A, Tong JH, Rodriguez L; High-performance liquid chromatographic method development and validation for the simultaneous quantitation of naproxen sodium and pseudoephedrine hydrochloride impurities; J Chromatogr Sci.; 2001; 39; 81-86.
6. Monser L, Darghouth F; Simultaneous determination of naproxen and related compounds by HPLC using porous graphitic carbon column; J Pharm Biomed Anal.; 2003; 32(4-5); 1087-1092.
7. Tashtoush B M, Al-Taani B M; HPLC determination of naproxen in plasma; Pharmazie; 2003; 58(9); 614-615.
8. Phillips T M, Wellner E F; Measurement of naproxen in human plasma by chip-based immuno affinity capillary electrophoresis; Biomed Chromatogr.; 2006; 20(6-7); 662-667.
9. Ashutosh Kumar S, Manidipa Debnath and Dr. Seshagiri Rao J. V. L. N; Simultaneous estimation of Esomeprazole and Naproxen in bulk as well as in pharmaceutical formulations by using RP-HPLC. Int J Pharm Sci Res.; 2013; 4(8); 2988-2999
10. Ashutosh Kumar S, Manidipa Debnath and Dr. Seshagiri Rao J. V. L. N.; Stability Indicating Simultaneous Estimation of Assay Method for Esomeprazole and Naproxen in Bulk as well as in Pharmaceutical Formulation by using RP-HPLC. World Journal of Pharmacy and Pharmaceutical Sciences. 2013; 2(4); 1897-1920.
11. Indian Pharmacopeia 2007, Volume I, Published by The Indian Pharmacopoeia Commission; 477-478.
12. Validation of analytical procedure: Methodology Q2B, ICH Harmonized Tripartite Guidelines; 1996; 1-8.
13. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH Harmonized tripartite guideline Validation of analytical procedures: Text and Methodology Q2 (R1) 6 November; 1996.
14. Ravichandran V, Shalini S, Sundram K. M and Harish Rajak; Validation of analytical methods– strategies & importance; International Journal of Pharmacy and Pharmaceutical Sciences; 2010; 2(3); 18-22
15. Tangri Pranshu, Rawat Prakash Singh, Jakhmola Vikash; Validation: A Critical Parameter for Quality Control of Pharmaceuticals; Journal of Drug Delivery & Therapeutics; 2012; 2(3); 34-40.
16. ICH harmonized tripartite guideline. Impurities in New Drug products Q3B (R2) current step 4 versions dated 2 June 2006.
17. Sharma Ajay, Sharma Rohit; Validation of analytical procedures: a comparison of ICH VS PHARMACOPOIEA (USP) and FDA; Inter National Research Journal of Pharmacy; 2012; 3(6); 39-42.
18. ICH, Validation of Analytical Procedure, Text and Methodology Q2 (R1), International conference on Harmonization, IFPMA, Geneve, Switzerland, 2005.
19. ICH harmonized tripartite guideline. Impurities in New Drug products Q3B (R2) current step 4 versions dated 2 June 2006.
20. International Conference on Harmonization, ICH Q1 A(R2); Stability Testing of New Drug Substances and Products 2003.
21. http://www.fda.gov/regulatoryinformation/guidances/ucm122049.htm.
.png)
